It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Use cases for Economic vs Market Index show when to rely on each signal, aiding risk assessment, timing, and portfolio adjustments.
28,511 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Pakistan's crypto regulators held talks with Islamic scholars after a fatwa labeled crypto purchases impermissible, s...
A major capital shift is unfolding as chipmakers gain ground while hyperscalers slow. NVIDIA and Micron are set to be...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
Investors await Intuitive Surgical’s Q2 release after a sharp YTD decline. Live updates will track da Vinci growth, u...
Renewed Iran tensions push Treasury yields higher and lift mortgage costs, threatening affordability for buyers and h...
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...
Analysts map a path for UPS through 2026 and beyond, highlighting margin resilience, volume growth, and cost control ...
NVIDIA is set to report fiscal Q4 results after the close, with traders betting on a top-line beat and a read on AI d...
Millennials hitting Peak 35 are wealthier than prior generations, signaling the great wealth transfer already underwa...
Thor Industries reports a dramatic EPS surprise for Q2, with revenue rising modestly. Yet cash flow weakness and unev...
Occidental Petroleum shares jump as geopolitical risk and Buffett’s investment strategy collide, fueling questions ab...